Leveraging AI in early stage drug discovery and due diligence: Autobahn Labs & Causaly webinar

Yiannis Kiachopoulos
July 7 2021
by Yiannis Kiachopoulos
open quotes
Switching over to Causaly has been transformative
close quotes
Dr. Yuxi Lin, Associate Director of Project Management at Autobahn Labs
open quotes
We want comfort in the therapeutic rationale that impacting Protein X will have a beneficial impact on Disease Y. You can do these searches in Google and get an impossible number of hits - but Causaly really allows us to drill down into these relationships and get supporting data for the directionality of the effect.
close quotes
Dr. Tom Novak, CSO at Autobahn Labs


Recommended Reads